February 11, 2026 06:36 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Bangladesh poll manifestos mirror India’s welfare schemes as BNP, Jamaat bet big on women, freebies | Drama ends: Pakistan makes U-turn on India boycott, to play T20 World Cup clash as per schedule | ‘Won’t allow any impediment in SIR’: Supreme Court pulls up Mamata govt over delay in sharing officers’ details | India-US trade deal: ‘Negotiations always two-way’, says Amul MD amid farmers’ concerns | Khamenei breaks 37-year-old ritual for first time amid escalating Iran-US tensions | India must push for energy independence amid global uncertainty: Vedanta chairman Anil Agarwal | Kanpur horror: Lamborghini driven by businessman’s son rams vehicles, injures six | ‘Namaste Trump beat Howdy Modi’: Congress slams PM Over India-US trade deal | Historic India-US trade pact: Tariffs cut, $500B market opportunity unlocked! | Big call from RBI: Repo rate stays at 5.25%, neutral stance continues

Novo Nordisk and IIIT Bangalore sign MoU to drive industry-academia research opportunities and skill development

| @indiablooms | May 24, 2023, at 06:15 am

Bengaluru: Novo Nordisk Global Business Services (GBS) and the International Institute of Information Technology, Bangalore (IIIT Bangalore) have inked a Memorandum of Understanding (MoU) to jointly engage in initiatives including research and innovation projects.

The partnership also includes activities like hackathons, case competitions, guest lectures, education programs, internships, placements, employee development, branding and corporate social responsibility collaborations.

The MoU will be effective from May 19, 2023, for a period of two years.

Commenting on the initiative, Mr. John Dawber, Corporate Vice President, and Managing Director of Novo Nordisk Global Business Services, said, "We are delighted to partner with IIIT Bangalore to develop deeper industry-academia collaboration with a specific emphasis on healthcare and pharma solutions that leverage technology and data to make a positive impact on patients’ lives.”

Novo Nordisk is expanding in Bangalore, adding more than 500 new skilled positions each year, delivering high levels of expertise and process excellence for our global company, he said.

“With access to the talent pool at IIIT Bangalore, we believe we can significantly enhance our innovation contribution to the Indian academic ecosystem and ultimately improve health," he added.

Prof. Debabrata Das, Director of IIIT Bangalore, added, "Our goal is to encourage cross-fertilization of ideas between academic researchers and technical experts from Novo Nordisk to drive innovation and develop novel solutions for the pharmaceutical industry."

Besides fostering knowledge sharing between industry and academia, the partnership will also provide students at IIIT Bangalore with opportunities to gain real-world experiences, develop new skills, and build relationships with leading industry professionals.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.